Moreover, MIF is modulated by glucocorticoids, and high, antiinflammatory doses of glucocorticoids inhibit MIF secretion; however, during pathological conditions characterized by glucocorticoid resistance, such as depression, it is conceivable that levels of MIF are increased (Bloom et al., 2014). Here, MIF is linked to depressive symptom measurement.